1. Home
  2. BGLC vs MKZR Comparison

BGLC vs MKZR Comparison

Compare BGLC & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • MKZR
  • Stock Information
  • Founded
  • BGLC 2017
  • MKZR 2012
  • Country
  • BGLC Malaysia
  • MKZR United States
  • Employees
  • BGLC N/A
  • MKZR N/A
  • Industry
  • BGLC Medical Specialities
  • MKZR
  • Sector
  • BGLC Health Care
  • MKZR
  • Exchange
  • BGLC Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • BGLC 10.4M
  • MKZR 10.3M
  • IPO Year
  • BGLC N/A
  • MKZR N/A
  • Fundamental
  • Price
  • BGLC $5.58
  • MKZR $6.72
  • Analyst Decision
  • BGLC
  • MKZR
  • Analyst Count
  • BGLC 0
  • MKZR 0
  • Target Price
  • BGLC N/A
  • MKZR N/A
  • AVG Volume (30 Days)
  • BGLC 176.1K
  • MKZR 39.9K
  • Earning Date
  • BGLC 11-14-2025
  • MKZR 11-11-2025
  • Dividend Yield
  • BGLC N/A
  • MKZR 34.75%
  • EPS Growth
  • BGLC N/A
  • MKZR N/A
  • EPS
  • BGLC N/A
  • MKZR N/A
  • Revenue
  • BGLC $9,551,559.00
  • MKZR $23,037,348.00
  • Revenue This Year
  • BGLC N/A
  • MKZR N/A
  • Revenue Next Year
  • BGLC N/A
  • MKZR N/A
  • P/E Ratio
  • BGLC N/A
  • MKZR N/A
  • Revenue Growth
  • BGLC 4.01
  • MKZR 52.64
  • 52 Week Low
  • BGLC $2.01
  • MKZR $3.89
  • 52 Week High
  • BGLC $15.60
  • MKZR $55.00
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 53.85
  • MKZR 66.14
  • Support Level
  • BGLC $4.20
  • MKZR $5.40
  • Resistance Level
  • BGLC $6.00
  • MKZR $6.99
  • Average True Range (ATR)
  • BGLC 0.33
  • MKZR 0.38
  • MACD
  • BGLC 0.04
  • MKZR 0.11
  • Stochastic Oscillator
  • BGLC 76.76
  • MKZR 84.03

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: